Publications & Works

Publication Network
Articles 74
All (74)
SCI-E, SSCI, AHCI (69)
SCI-E, SSCI, AHCI, ESCI (73)
ESCI (4)
Scopus (68)
TRDizin (29)
Other Publications (1)

1. Examination of drug removal profiles in patients undergoing therapeutic plasma exchange: A retrospective study

Balaban U., Kara E., Mahmoud S. H., Özcebe O. İ., Demirkan S. K.
THERAPEUTIC APHERESIS AND DIALYSIS , vol.28, no.6, pp.954-963, 2024 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

2. Antimicrobial management in patients undergoing therapeutic plasma exchange: A Cross-Sectional Nationwide Survey

Balaban U., Kara E., Pınar A., Özcebe O. İ., Demirkan S. K., Ünal S.
JOURNAL OF INVESTIGATIVE MEDICINE , no.8, pp.920-929, 2024 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

3. Effect of therapeutic plasma exchange on antimicrobials in critically ill patients

Balaban U., Kara E., Kaya E. K., Özcebe O. İ., Akova M., Topeli İskit A., et al.
CRITICAL CARE , no.1, 2024 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

4. Hypophosphatemia related to the use of ibrutinib

KARADENİZ M., ÇINAR O. E., Erdogdu B., MALKAN Ü. Y., GÖKER H., ÖZCEBE O. İ.
Journal of Oncology Pharmacy Practice , 2023 (SCI-Expanded, Scopus) identifier identifier identifier

5. A single-center experience of haploidentical stem cell transplantation in hematological malignancies

MALKAN Ü. Y., GÖKER H., DEMİROĞLU H., Tekin F., Akdemir B., ALADAĞ KARAKULAK E., et al.
Turkish Journal of Medical Sciences , vol.53, no.1, pp.352-359, 2023 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier identifier

6. Hemoglobin cast nephropathy: a rare but serious complication of hemolysis in a pediatric patient

BALTU D., Oral N. A., KESİCİ S., TOPALOĞLU R., ÖZCEBE O. İ., AKSU T., et al.
Turkish Journal of Pediatrics , vol.65, no.5, pp.874-880, 2023 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier identifier

7. Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantation

KARATAŞ A., GÖKER H., DEMİROĞLU H., MALKAN Ü. Y., Velet M., ÇINAR O. E., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , vol.52, no.2, pp.413-419, 2022 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

8. Platelet-rich plasma treatment improves postoperative recovery in patients with pilonidal sinus disease: a randomized controlled clinical trial

Boztug C. Y., KARAAĞAÇ AKYOL T., Benlice C., KOÇ M. A., Doganay Erdogan B., ÖZCEBE O. İ., et al.
BMC SURGERY , vol.21, no.1, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

9. Long-term results of allogeneic peripheral blood hematopoietic stem cell transplantation for severe aplastic anemia

ALADAĞ KARAKULAK E., GÖKER H., DEMİROĞLU H., AKSU S., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.60, no.2, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

10. Allogeneic Hematopoietic Stem-Cell Transplantation Improves Disease-Free Survival Compared to Pediatric-Inspired Berlin-Frankfurt-Munster Chemotherapy in Adult Acute Lymphoblastic Leukemia

ALADAĞ KARAKULAK E., Aktimur S. H., Aydin O., DEMİROĞLU H., BÜYÜKAŞIK Y., AKSU S., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.21, no.3, pp.147-153, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

11. Mental status and physical activity in patients with homozygous familial hypercholesterolemia: A subgroup analysis of a nationwide survey (A-HIT1 registry)

KUMAN TUNÇEL Ö., Kayikcioglu M., PIRILDAR Ş., YILMAZ M., KAYNAR L., Aktan M., et al.
JOURNAL OF CLINICAL LIPIDOLOGY , vol.14, no.3, pp.361-372, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

12. Clinical management, psychosocial characteristics, and quality of life in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis in Turkey: Results of a nationwide survey (A-HIT1 registry)

Kayikcioglu M., Kuman-Tuncel O., Pirildar S., YILMAZ M., KAYNAR L., Aktan M., et al.
JOURNAL OF CLINICAL LIPIDOLOGY , vol.13, no.3, pp.455-467, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

13. The Turkish experience with therapeutic plasma exchange: A national survey

Korkmaz S., Medeni S. S., DEMİRKAN F., Besisik S. K., Dadin S. A., ÇAĞLIYAN G. A., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.58, no.3, pp.287-292, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

14. CYTOGENETIC ANOMALIES IN MULTIPLE MYELOMA PATIENTS: A SINGLE CENTER STUDY

BOZKURT S., BÜYÜKAŞIK Y., DEMİROĞLU H., ALADAĞ KARAKULAK E., OKAY M., KARATAŞ A., et al.
Genetics and Application , vol.3, no.1, pp.51-56, 2019 (Peer-Reviewed Journal)

15. Unclassifiable non-CML classical myeloproliferative diseases with microcytosis: findings indicating diagnosis of polycythemia vera masked by iron deficiency

ALADAĞ KARAKULAK E., AKSU S., DEMİROĞLU H., SAYINALP N., GÖKER H., HAZNEDAROĞLU İ. C., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , vol.49, no.5, pp.1560-1563, 2019 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier

16. Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., Malkan Ü. Y., Ciftciler R., ALADAĞ KARAKULAK E., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , vol.49, no.4, pp.985-992, 2019 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier

17. What have we learned from Turkish familial hypercholesterolemia registries (A-HIT1 and A-HIT2)?

Kayikcioglu M., Tokgozoglu L., DOĞAN V., CEYHAN C., TUNÇEZ A., KUTLU M., et al.
ATHEROSCLEROSIS , vol.277, pp.341-346, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

18. Evaluation of Secondary Malignancies in Chronic Lymphocytic Leukemia

DEMİROĞLU H., SAYINALP N., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ., HAZNEDAROĞLU İ. C., et al.
Journal of Global Oncology , pp.205, 2018 (ESCI)

19. Therapeutic plasma exchange for refractory SLE:A comparison of outcomes between different sub-phenotypes

Soyuoz A., KARADAĞ Ö., Karaagac T., KILIÇ L., Bilgen Ş. Ş., ÖZCEBE O. İ.
EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.5, no.1, pp.32-36, 2018 (ESCI, TRDizin) identifier identifier

20. A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)

Kayikcioglu M., Tokgozoglu L., YILMAZ M., KAYNAR L., Aktan M., Durmus R. B., et al.
ATHEROSCLEROSIS , vol.270, pp.42-48, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

21. A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 study

Tekgunduz E., YILMAZ M., ERKURT M. A., KİKİ İ., Kaya A. H., KAYNAR L., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.57, no.1, pp.27-30, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

22. Pediatric Chemotherapeutic Regimen (BFM-95) is Superior for Overall Survival in Adult Acute Lymphoblastic Leukemia

KARCIOĞLU A. M., OKAY M., BÜYÜKAŞIK Y., Malkan Ü. Y., SAYINALP N., DEMİROĞLU H., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.28, no.4, pp.254-260, 2018 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier

23. The impact of chemo/immune therapy-related cytopenias on the clinical course of chronic lymphoid leukemia

Malkan Ü. Y., OKAY M., HAZNEDAROĞLU İ. C., GÜNEŞ G., Aslan N. A., ÖZCEBE O. İ., et al.
LEUKEMIA & LYMPHOMA , vol.58, pp.96, 2017 (SCI-Expanded) identifier

24. Leukapheresis do not improve early death rates in acute myeloid leukemia patients with hyperleukocytosis

Malkan Ü. Y., ÖZCEBE O. İ.
TRANSFUSION AND APHERESIS SCIENCE , vol.56, no.6, pp.880-882, 2017 (SCI-Expanded, Scopus) identifier identifier identifier

25. Sole Infrequent Karyotypic Aberration Trisomy 6 in a Patient with Acute Myeloid Leukemia and Breast Cancer in Remission

AYDIN M. S., BOZKURT S., GÜNEŞ G., Malkan Ü. Y., Aslan T., ETGÜL S., et al.
TURKISH JOURNAL OF HEMATOLOGY , vol.34, no.1, pp.103-104, 2017 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sustainable Development identifier identifier identifier

26. Comparison of Myelodysplastic Syndrome Prognostic Scoring Systems

BEKTAŞ Ö., ÜNER A., ELİAÇIK E., Uz B., Isik A., ETGÜL S., et al.
TURKISH JOURNAL OF HEMATOLOGY , vol.33, no.2, pp.119-126, 2016 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier

27. The Prognosis of Adult Burkitt's Cell Leukemia in Real-Life Clinical Practice

Malkan Ü. Y., GÜNEŞ G., GÖKER H., HAZNEDAROĞLU İ. C., Acar K., ELİAÇIK E., et al.
TURKISH JOURNAL OF HEMATOLOGY , vol.33, no.4, pp.281-285, 2016 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier

28. The Impact of Iron Overload on Transplant-Related Complications and Prognosis of Acute Leukemias

Malkan U. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C., Yayar O., ETGÜL S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.26, no.1, pp.54-60, 2016 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier

29. The Impact of Jak1/Jak2 Inhibitor Ruxolitinib on the Spleen Size and Symptom Burden in Myeloproliferative Diseases

Aktimur S. H., Malkan U. Y., Eyupoglu D. N., HAZNEDAROĞLU İ. C., KELKİTLİ E., Atay H. M., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.26, no.3, pp.153-158, 2016 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sustainable Development identifier identifier

30. High frequency of autonomous T-cell proliferation compatible with T-cell large granular lymphocytic leukemia in patients with cytopenia of unknown etiology

BEKTAŞ Ö., ÜNER A., Aydin S. M., ELİAÇIK E., Uz B., Isik A., et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY , vol.102, no.2, pp.211-217, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

31. The factors affecting early death after the initial therapy of acute myeloid leukemia

Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C., ETGÜL S., Aslan T., et al.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , vol.8, no.12, pp.22564-22569, 2015 (SCI-Expanded, Scopus) identifier identifier

32. Rebound Thrombocytosis following Induction Chemotherapy Is an Independent Predictor of a Good Prognosis in Acute Myeloid Leukemia Patients Attaining First Complete Remission

Malkan Ü. Y., Gunes G., Isik A., Eliacik E., Etgul S., Aslan T., et al.
ACTA HAEMATOLOGICA , vol.134, no.1, pp.32-37, 2015 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

33. Pharmacobiological Approach for the Clinical Development of Ruxolitinib in Myeloproliferative Neoplasms

ELİAÇIK E., Isik A., AKSU S., ÜNER A., BÜYÜKAŞIK Y., SAYINALP N., et al.
TURKISH JOURNAL OF HEMATOLOGY , vol.32, no.2, pp.163-167, 2015 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier

34. Clinicopathological associations of acquired erythroblastopenia

GÜNEŞ G., Malkan Ü. Y., YAŞAR H. A., ELİAÇIK E., HAZNEDAROĞLU İ. C., DEMİROĞLU H., et al.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , vol.8, no.12, pp.22515-22519, 2015 (SCI-Expanded, Scopus) identifier identifier

35. Massive Life-Threatening Hemorrhages Due to Toxic Oral Intake of 3750 Mg Dabigatran Etexilate As a Suicide Attempt and the Clinical Management

GÜNEŞ G., Malkan Ü. Y., AKSU S., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y., SAYINALP N., et al.
BLOOD , vol.124, no.21, 2014 (SCI-Expanded, Scopus) Sustainable Development identifier

36. Rebound Thrombocytosis Is an Independent Predictor of Good Prognosis in AML Patients Attaining First Complete Remission

Malkan Ü. Y., GÜNEŞ G., GÖKER H., ELİAÇIK E., Isik A., SAYINALP N., et al.
BLOOD , vol.124, no.21, 2014 (SCI-Expanded, Scopus) identifier

37. Local Renin-Angiotensin System in Normal Hematopoietic and Multiple Myeloma-Related Progenitor Cells

Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Hatirnaz O., AKSU S., et al.
TURKISH JOURNAL OF HEMATOLOGY , vol.31, no.2, pp.136-142, 2014 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier

38. Vitamin B-12 Deficiency with the Absence of Anemia in Young and Middle-Aged Population

Kara A., Eliacik E., BÜYÜKAŞIK Y., ÖZCEBE O. İ., Haznedaroglu I., AKSU S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.24, no.3, pp.190-194, 2014 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sustainable Development identifier identifier

39. An Immune Thrombocytopenic Purpura-Like Picture Preceding Chronic Myelomonocytic Leukemia: A Case Series and Review of the Literature

Albayrak M., ELİAÇIK E., KORUCU B., Isik A., GÜNEŞ G., AKSU S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.24, no.3, pp.213-216, 2014 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier

40. Local hematopoietic renin-angiotensin system in myeloid versus lymphoid hematological neoplastic disorders

Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Ng O. H., BÜYÜKAŞIK Y., et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM , vol.14, no.4, pp.308-314, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

41. Co-expression of t(5;17) and t(8;21) in a Case of Acute Promyelocytic Leukemia: Review of the Literature

Uz B., ELİAÇIK E., Isik A., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.
TURKISH JOURNAL OF HEMATOLOGY , vol.30, no.4, pp.400-404, 2013 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier

42. EUTOS CML prognostic scoring system predicts ELN-based 'event-free survival' better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate

Uz B., BÜYÜKAŞIK Y., Atay H., KELKİTLİ E., Turgut M., BEKTAŞ Ö., et al.
HEMATOLOGY , vol.18, no.5, pp.247-252, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

43. Spot analyses of serum neopterin, tryptophan and kynurenine levels in a random group of blood donor population

Unuvar S., GİRGİN G., PALABIYIK Ş. S., Karaagac T., ÖZCEBE O. İ., Sahin G., et al.
PTERIDINES , vol.24, no.1, pp.41-46, 2013 (SCI-Expanded, Scopus) Sustainable Development identifier identifier

44. Review of therapeutic options and the management of patients with myelodysplastic syndromes

ÖZCAN M. A., İLHAN O., ÖZCEBE O. İ., Nalcaci M., Gulbas Z.
EXPERT REVIEW OF HEMATOLOGY , vol.6, no.2, pp.165-189, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

45. Renin-Angiotensin System (RAS) Expressions in Myeloid Leukemic Cell Lines

Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Hatirnaz Ng O., BÜYÜKAŞIK Y., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.23, no.4, pp.264-268, 2013 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier

46. Bone Marrow Iron Staining is a Reliable Test for Elimination of Iron Deficiency Anemia Rather than its Diagnosis

Koca E., Cetiner D. A., BÜYÜKAŞIK Y., ÜNER A., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.23, no.4, pp.260-263, 2013 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier

47. Nasal Natural Killer/T-cell Lymphoma with Skin, Eye, and Peroneal Nerve Involvement

Turker B., Uz B., Isik M., BEKTAŞ Ö., DEMİROĞLU H., SAYINALP N., et al.
TURKISH JOURNAL OF HEMATOLOGY , vol.29, no.4, pp.413-419, 2012 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier

48. An Evaluation of Hormone Levels in Behcet's Disease

Karakus S., Nar A., Toprak S. K., Atalay F., ÖZCEBE O. İ.
TURKISH JOURNAL OF RHEUMATOLOGY , vol.27, no.3, pp.158-164, 2012 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier

49. How do we collect better granulocyte?

Akyol T. K., Buyukasik Y., Aksu S., Ozcebe O. I.
TRANSFUSION AND APHERESIS SCIENCE , vol.47, no.1, pp.107-111, 2012 (SCI-Expanded, Scopus) identifier identifier identifier

50. Discovering Blood Donor Arrival Patterns Using Data Mining: A Method to Investigate Service Quality at Blood Centers

TESTİK M. C., OZKAYA B., AKSU S., ÖZCEBE O. İ.
JOURNAL OF MEDICAL SYSTEMS , vol.36, no.2, pp.579-594, 2012 (SCI-Expanded, SSCI, Scopus) identifier identifier identifier

51. Toscana Virus (TOSV) exposure is confirmed in blood donors from Central, North and South/Southeast Anatolia, Turkey

ERGÜNAY K., AYDOĞAN S. H., ÖZCEBE O. İ., Cilek E. E., Hacioglu S., Karakaya J., et al.
ZOONOSES AND PUBLIC HEALTH , vol.59, no.2, pp.148-154, 2012 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

52. Hunter syndrome and new onset idiopathic thrombocytopenic purpura in a young patient

Uz B., DEMİROĞLU H., ÖZCEBE O. İ.
ANNALS OF HEMATOLOGY , vol.91, no.2, pp.303-304, 2012 (SCI-Expanded, Scopus) identifier identifier identifier

53. Unusual Extramedullary Recurrence and Renal Relapse Despite Complete Chimerysm after Allografting in Ph+ ALL

Serefhanoglu S., GÖKER H., BAYDAR D., ÜNER A., ARICI M., HAZNEDAROĞLU İ. C., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.22, no.1, pp.46-50, 2012 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier

54. Eculizumab before and after allogeneic hematopoietic stem cell transplantation in a patient with paroxysmal nocturnal hemoglobinuria

GÖKER H., Uz B., BÜYÜKAŞIK Y., AKSU S., Haznedaroglu I., SAYINALP N., et al.
TURKISH JOURNAL OF HEMATOLOGY , vol.28, no.3, pp.223-227, 2011 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier

55. Identification of clinical and simple laboratory variables predicting responsible gastrointestinal lesions in patients with iron deficiency anemia

Serefhanoglu S., BÜYÜKAŞIK Y., Emmungil H., SAYINALP N., HAZNEDAROĞLU İ. C., GÖKER H., et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES , vol.8, no.1, pp.30-38, 2011 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

56. THE FACTORS INFLUENCING OVERALL SURVIVAL IN NEWLY DIAGNOSED ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

Serefhanoglu S., BÜYÜKAŞIK Y., AKSU S., GÖKER H., SAYINALP N., Cetgner D., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.74, no.1, pp.7-12, 2011 (ESCI, TRDizin) identifier

57. Investigation of West Nile Virus Seroprevalence in Hacettepe University Hospital Blood Donors and Confirmation of the Positive Results by Plaque Reduction Neutralization Test

Ayturan S., AYDOĞAN S., ERGÜNAY K., ÖZCEBE O. İ., Us D.
MIKROBIYOLOJI BULTENI , vol.45, no.1, pp.113-124, 2011 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

58. Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and anthracyclines (PETHEMA protocol) therapy

SEREFHANOGLU S., BÜYÜKAŞIK Y., GÖKER H., SAYINALP N., HAZNEDAROĞLU İ. C., AKSU S., et al.
LEUKEMIA RESEARCH , vol.34, no.12, 2010 (SCI-Expanded, Scopus) identifier identifier identifier

59. Prognostic Factors Affecting the Clinical Course of non-Hodgkin's Lymphomas

Beyazit Y., Kekilli M., Purnak T., GÖKER H., AKSU S., HAZNEDAROĞLU İ. C., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.20, no.2, pp.96-102, 2010 (SCI-Expanded, Scopus, TRDizin) identifier identifier

60. Concomitant renal cell carcinoma and lymphoid malignancies: a case series of five patients and review of the literature

Serefhanoglu S., BÜYÜKAŞIK Y., GÖKER H., Akin S. C., Akin S., SAYINALP N., et al.
MEDICAL ONCOLOGY , vol.27, no.1, pp.55-58, 2010 (SCI-Expanded, Scopus) identifier identifier identifier

61. DISEASE CHARACTERISTICS AND FACTORS INFLUENCING TREATMENT RESPONSE IN NEWLY DIAGNOSED ACUTE MYELOBLASTIC LEUKEMIA PATIENTS: A SINGLE CENTER EXPERIENCE

Serefhanoglu S., BÜYÜKAŞIK Y., AKSU S., GÖKER H., SAYINALP N., Cetiner D., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.73, no.3, pp.74-79, 2010 (ESCI, TRDizin) identifier

62. The Gray-Zone Concept, Suboptimal Response to Imatinib, Shall be Removed from the ELN-CML Recommendations

HAZNEDAROĞLU İ. C., Koca E., AKSU S., GÖKER H., SAYINALP N., BÜYÜKAŞIK Y., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.20, no.2, pp.25-26, 2010 (SCI-Expanded, Scopus, TRDizin) identifier identifier

63. Spinal Myeloid Sarcoma in Two Non-Leukemic Patients

Serefhanoglu S., GÖKER H., AKSU S., BÜYÜKAŞIK Y., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
INTERNAL MEDICINE , vol.49, no.22, pp.2493-2497, 2010 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

64. Dasatinib-Induced Tumor Lysis Syndrome and Following Hematologic Remission in Fibrotic Blastic Crisis of CML

BEKTAŞ Ö., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y., SAYINALP N., AKSU S., GÖKER H., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.20, no.2, pp.13-16, 2010 (SCI-Expanded, Scopus, TRDizin) identifier identifier

65. Changes in vascular endothelial growth factor, angiopoietins, and Tie-2 levels with G-CSF stimulation in healthy donors

Serefhanoglu S., GÖKER H., BÜYÜKAŞIK Y., Turgut M., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
ANNALS OF HEMATOLOGY , vol.88, no.7, pp.667-671, 2009 (SCI-Expanded, Scopus) identifier identifier identifier

66. Transformation of Adult Myelodysplastic Syndrome-Refractory Anemia to Acute T-Cell Lymphoblastic Leukemia

Serefhanoglu S., GÖKER H., BÜYÜKAŞIK Y., SAYINALP N., ÖZCEBE O. İ.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , vol.101, no.4, pp.370-372, 2009 (SCI-Expanded, Scopus) identifier identifier

67. The Effect of the Chernobyl Disaster on the Occurrence of Adult Acute Leukemias in Turkey

Ozatli D., GÖKER H., Buyuhasik Y., Sayinalp N., HAZNEDAROĞLU İ. C., ÖZCEBE O. İ.
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , vol.29, no.2, pp.388-394, 2009 (SCI-Expanded, Scopus) identifier

68. Biphenotypic Acute Leukemia Treated With Acute Myeloid Leukemia Regimens: A Case Series

Serefhanoglu S., BÜYÜKAŞIK Y., GÖKER H., SAYINALP N., ÖZCEBE O. İ.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , vol.101, no.3, pp.270-272, 2009 (SCI-Expanded, Scopus) identifier identifier identifier

69. Multiple Bulky Cutaneous Plasmacytomas with CNS Relapse without Bone Marrow Involvement during the Course of a Lambda Light Chain Myeloma

Serefhanoglu S., HAZNEDAROĞLU İ. C., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ.
ONKOLOGIE , vol.32, no.11, pp.662-664, 2009 (SCI-Expanded, Scopus) identifier identifier identifier

70. Extramedullary plasmacytomas of the thyroid and pericardium as initial presentation of multiple myeloma

Serefhanoglu S., SAYINALP N., HAZNEDAROĞLU İ. C., GÖKER H., Cetiner D., AKSU S., et al.
ANNALS OF HEMATOLOGY , vol.87, no.10, pp.853-854, 2008 (SCI-Expanded, Scopus) identifier identifier identifier

71. Soluble platelet glycoprotein V in distinct disease states of pathological thrombopoiesis

Acar K., AKSU S., Beyazit Y., HAZNEDAROĞLU İ. C., Koca E., Cetiner D., et al.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , vol.100, no.1, pp.86-90, 2008 (SCI-Expanded, Scopus) identifier identifier identifier

72. Global assessment of the coagulation status in type 2 diabetes mellitus using rotation thromboelastography

Yurekli B. P. S., Ozcebe O. I., Kirazli S., Gurlek A.
BLOOD COAGULATION & FIBRINOLYSIS , vol.17, no.7, pp.545-549, 2006 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

73. Plasma levels of coagulation and fibrinolysis markers in acute ischemic stroke patients with lone atrial fibrillation

Topcuoglu M. A., HAYDARI D., ÖZTÜRK Ş., Ozcebe O. İ., SARİBAS O.
NEUROLOGICAL SCIENCES , vol.21, no.4, pp.235-240, 2000 (SCI-Expanded, Scopus) identifier identifier

74. Efficacy of sulbactam-ampicillin for the treatment of severe diabetic foot infections

Akova M., Ozcebe O. İ., Gullu I., Unal S., GUR D., AKALIN S., et al.
JOURNAL OF CHEMOTHERAPY , vol.8, no.4, pp.284-289, 1996 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier
Papers Presented at Peer-Reviewed Scientific Conferences 29

1. THE EVALUATION OF THE CLINICOPATHOLOGIC CHARACTERISTICS OF T-CELL NON-HODGKIN’S LYMPHOMA: THE SINGLE CENTER EXPERIENCE

SAYINALP N., ALADAĞ KARAKULAK E., OKAY M., ÇİFTÇİLER R., AKSU S., DEMİROĞLU H., et al.
15th International Conference on Malignant Lymphoma, Switzerland, 18 - 22 June 2019, vol.37, pp.366, (Summary Text)

2. ASEMPTOMATİK D-DİMER YÜKSEKLİĞİ İMMÜNMONULATUAR KULLANAN MULTİPLE MYELOMADA TROMBOZU TAHMİN EDER Mİ: GERÇEK YAŞAM VERİSİ

AYDIN M. S., ALADAĞ KARAKULAK E., ÇİFTÇİLER R., YAZGAN S. Ç., DEMİROĞLU H., ÖZCEBE O. İ., et al.
4. ULUSAL KAN VE KEMİK İLİĞİ NAKLİ KONGRESİ, Cyprus (Kktc), 4 - 06 April 2019, (Summary Text)

3. ALLOJENİK KÖK HÜCRE NAKLİ SONRASI RELAPS İZLENEN AKUT LÖSEMİ HASTALARINDA TEDAVİ SEÇENEKLERİ: DONÖR LENFOSİT İNFUZYONU VE İKİNCİ ALLOJENİK KÖK HÜCRE NAKLİNİN KARŞILAŞTIRILMASI

ALADAĞ KARAKULAK E., DEMİROĞLU H., BÜYÜKAŞIK Y., OKAY M., ÇİFTÇİLER R., SAYINALP N., et al.
4. ULUSAL KAN VE KEMİK İLİĞİ NAKLİ KONGRESİ, Cyprus (Kktc), 4 - 06 April 2019, (Summary Text)

4. MULTİPLE MYELOM HASTALARINDA İNDUKSİYON TEDAVİ SÜRESİNİN SAĞKALIMA ETKİSİ

ALADAĞ KARAKULAK E., OKAY M., ÇİFTÇİLER R., DEMİROĞLU H., AKSU S., BÜYÜKAŞIK Y., et al.
3. HEMATOLOJİK İMMUNOLOJİ KONGRESİ, Turkey, 8 - 09 March 2019, (Summary Text)

5. DASATİNİB KULLANIRKEN PLEVRAL EFFÜZYONU GELİŞİP, KÜÇÜK HÜCRELİ AKCİĞER KANSERİ TANISI ALAN BİR OLGU

ÇİFTÇİLER R., ALADAĞ KARAKULAK E., SAYINALP N., HAZNEDAROĞLU İ. C., ÖZCEBE O. İ., AKSU S., et al.
44. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 31 October - 03 November 2018, pp.364-365, (Summary Text) Sustainable Development

6. T HÜCRELİ LENFOMA HASTALARININ KLİNİK ÖZELLİKLERİNİN DEĞERLENDİRİLMESİ: TANIDAN PROGNOZA TEK MERKEZ DENEYİMİ

DEMİROĞLU H., SAYINALP N., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ., HAZNEDAROĞLU İ. C., et al.
TÜRK HEMATOLOJİ DERNEĞİ, Turkey, 31 October - 03 November 2018, (Full Text)

7. MRG’DE TESADÜFEN SAPTANAN KEMİK İLİĞİNİN DİFFÜZ SİNYAL DEĞİŞİKLİKLERİ LENFOHEMATOPOETİK HASTALIKLARI ÖNGÖREBİLİR Mİ?

ÇİFTÇİLER R., ALADAĞ KARAKULAK E., AKSU S., SAYINALP N., DEMİROĞLU H., GÖKER H., et al.
44. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 31 October - 03 November 2018, pp.266, (Summary Text)

8. LENALIDOMID İLE MYELOMDA OTOLOG NAKİL SONRASI İLK NÜKSDE TALİDOMİD VE BORTEZOMİBE KIYASLA DAHA İYİ İLERLEMESİZ SAĞKALIM

DEMİROĞLU H., AKSU S., SAYINALP N., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ., et al.
TÜRK HEMATOLOJİ DERNEĞİ, Turkey, 31 October - 03 November 2018, (Full Text)

9. AĞIR APLASTİK ANEMİ HASTALARINDA HEMATOPOETİK KÖK HÜCRE NAKLİNDE KULLANILAN HAZIRLIK REJİMLERİNİN KARŞILAŞTIRILMASI

ALADAĞ KARAKULAK E., DEMİROĞLU H., ÇİFTÇİLER R., BÜYÜKAŞIK Y., SAYINALP N., AKSU S., et al.
44.ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 31 October - 03 November 2018, pp.261, (Summary Text)

10. BRENTIXUMAB VEDOTIN IN CD30 LYMPHOMAS: SINGLE CENTER EXPERIENCE

DEMİROĞLU H., SAYINALP N., BÜYÜKAŞIK Y., ÖZCEBE O. İ., HAZNEDAROĞLU İ. C., GÖKER H., et al.
IX. INTERNATIONAL EHOC, 17 - 20 October 2018, vol.73, (Full Text)

11. Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., MALKAN Ü. Y., CIFTCILER R., Aladag E., et al.
9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, (Summary Text) Creative Commons License identifier identifier identifier

12. RELAPS/REFRAKTER LENFOMADA OTOLOG KÖK HÜCRE TRANSPLANTASYONUNDA MİTOKSANNTRON-MELFALAN HAZIRLAMA REJİMİ

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., malkan Ü. Y., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., et al.
6. HEMATOLOJİK ONKOLOJİ KONGRESİ, Turkey, 18 - 22 September 2018, (Full Text)

13. RELAPS/REFRAKTER LENFOMADA OTOLOG KÖK HÜCRE TRANSPLANTASYONUNDA MİTOKSANTRON-MELFALAN HAZIRLAMA REJİMİ

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., MALKAN Ü. Y., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., et al.
5. HEMATOLOJİK ONKOLOJİ KONGRESİ, Cyprus (Kktc), 20 - 22 September 2018, (Summary Text)

14. AKUT MYELOİD LÖSEMİLİ BİR OLGULDA SİTOZİN ARABİNOZİD İLİŞKİLİ PULMONER TOKSİSİTE

ÇİFTÇİLER R., ALADAĞ KARAKULAK E., HAZNEDAROĞLU İ. C., AKSU S., DEMİROĞLU H., GÖKER H., et al.
4.İLAÇ VE TEDAVİ KONGRESİ, Cyprus (Kktc), 19 - 23 September 2018, pp.254, (Summary Text)

15. EFFECT OF THE INDUCTION THERAPY ON SURVIVAL IN MULTIPLE MYELOMA PATIENTS

ALADAĞ KARAKULAK E., ÇİFTÇİLER R., DEMİROĞLU H., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.
The International Congress of BMT 2018, Busan, South Korea, 30 August - 01 September 2018, (Summary Text)

16. DOES ASYMPTOMATIC D-DIMER ELEVATION PREDICT THROMBOSIS IN PATIENTS ON IMMUNOMODULATORY DRUGS IN MULTIPLE MYELOMA: REAL-LIFE DATA

AYDIN M. S., YAZGAN S. Ç., ALADAĞ KARAKULAK E., ÇİFTÇİLER R., KELKİTLİ E., TURGUT M., et al.
23rd Congress of EHA, Stockholm, Sweden, 14 - 17 June 2018, (Summary Text)

17. Does Asymptomatic D-Dimer Elevation Predict Thrombosis in Patient on Immunomodulatory Drugs in Multiple Myeloma: Real-Life Data

AYDIN M. S., YAZGAN S. C., ALADAĞ KARAKULAK E., Çiftçiler R., KELKİTLİ E., TURGUT M., et al.
European Hemtology Association, 14 - 17 June 2018, (Summary Text)

18. KRONİK LENFOSİTİK LÖSEMİ HASTALARINDA İKİNCİL MALİGNİTELERİN DEĞERLENDİRİLMESİ

ALADAĞ KARAKULAK E., OKAY M., ÇİFTÇİLER R., HEZİYEV T., BÜYÜKAŞIK Y., SAYINALP N., et al.
2. HEMATOLOJİK İMMUNOLOJİ KONGRESİ, Cyprus (Kktc), 4 - 06 May 2018, (Summary Text)

19. Common medical problems in adult patients with Hemophilia A: A single center experience

AYDIN M. S., OKAY M., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., DEMİROĞLU H., GÖKER H., et al.
15. INTERNATIONAL HEMOPHILIA CONGRESS OF TURKEY, İstanbul, Turkey, 4 - 07 April 2018, (Summary Text)

20. Erken Evre Kronik Lenfositer Löseminin Nadir Görünümleri ve Bir Mide Kanseri Vakası Birlikteliği: 2 vaka sunumu.

AYDIN M. S., ÜNER A., OKAY M., MALKAN Ü. Y., BÜYÜKAŞIK Y., ÖZCEBE O. İ., et al.
43. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 31 October - 05 November 2017, vol.1, pp.66, (Summary Text) Sustainable Development

21. RARE PRESENTATIONS OF EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA AND A COINCIDENCE WITH GASTRIC CANCER: 2 CASES

AYDIN M. S., ÜNER A., malkan Ü. Y., OKAY M., BÜYÜKAŞIK Y., ÖZCEBE O. İ., et al.
LEUKEMIA RESEARCH, İstanbul, Turkey, 18 - 21 October 2017, vol.61, pp.16, (Summary Text) Sustainable Development identifier

22. EFFECT OF INDUCTION THERAPY ON SURVIVAL IN MULTIPLE MYELOMA PATIENTS

DEMİROĞLU H., ALADAĞ KARAKULAK E., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., SAYINALP N., et al.
INTERNATIONAL CONGRESS OF BMT 2018, Busan, South Korea, 30 August - 01 September 2018, vol.53, (Full Text)

23. The Impact of Chemo/Immune Therapy-­‐Related Cytopeniason the Clinical Course of Chronic Lymphoid Leukemia

OKAY M., HAZNEDAROĞLU İ. C., malkan Ü. Y., GÜNEŞ G., aslan n., AKSU S., et al.
iwcll2017, New York, United States Of America, 12 - 15 May 2017, (Summary Text)

24. A Multicenter Experience of Thrombotic Microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 Study

Tekgunduz E., YILMAZ M., ERKURT M. A., KİKİ İ., KAYA E., KAYNAR L., et al.
58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), California, United States Of America, 3 - 06 December 2016, vol.128, (Summary Text) identifier

25. AN ACUTE MYELOID LEUKEMIA PATIENT COMPLICATED WITH HYPERLEUKOCYTOSIS

Malkan Ü. Y., GÜNEŞ G., Yayar O., HAZNEDAROĞLU İ. C., AKSU S., ÖZCEBE O. İ.
6th International Eurasian Hematology Congress, Antalya, Turkey, 14 - 18 October 2015, vol.39, (Summary Text) identifier

26. SUCCESSFUL TREATMENT OF RESISTANT CHRONIC GRAFT VERSUS HOST DISEASE WITH EXTRACORPOREAL PHOTOPHERESIS IN A PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENT WHO HAS UNDERGONE ALLOGENEIC STEM CELL TRANSPLANTATION

Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., Yayar O., GÖKER H., ÖZCEBE O. İ.
6th International Eurasian Hematology Congress, Antalya, Turkey, 14 - 18 October 2015, vol.39, (Summary Text) identifier

27. A CHRONIC MYELOID LEUKEMIA CASE WHO HAS DISCONTINUED IMATINIB TREATMENT

Malkan Ü. Y., GÜNEŞ G., Aslan T., Yayar O., ÖZCEBE O. İ., HAZNEDAROĞLU İ. C.
6th International Eurasian Hematology Congress, Antalya, Turkey, 14 - 18 October 2015, vol.39, (Summary Text) identifier

28. Lower Doses of Plerixafor Use Is Sufficient to Effectively Mobilize PBSC (Peripheral Blood Hematopoetic Stem Cells) When Compared to Standard Administration

GÖKER H., ELİAÇIK E., Altuntas F., Tekgunduz E., ÖZDEMİR E., Isik A., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Costa Rica, 6 - 09 December 2014, vol.124, (Summary Text) identifier

29. GENERIC IMATINIB MESYLATE IS AS EFFECTIVE AS ORIGINAL GLIVEC IN THE MANAGEMENT OF CML

AKSU S., AKTİMUR S., ARİCA D., ATAY M. H., BEKTAŞ Ö., BÜYÜKAŞIK Y., et al.
20th Congress of the European Hematology Association Vienna, Austria June 11-14,2015, 11 - 14 June 2014, (Full Text)
Metrics

Publication

106

Publication (WoS)

80

Publication (Scopus)

69

Citation (WoS)

328

H-Index (WoS)

11

Citation (Scopus)

308

H-Index (Scopus)

11

Citation (Sum Other)

1

Project

1

Open Access

26
UN Sustainable Development Goals